Recent Approaches in Portal Hypertension Involving Risk Stratification and Medical Management

Abstract: Portal hypertension leads to the formation of portosystemic collaterals that divert portal blood to the systemic circulation and bypass the liver, resulting in multiple severe […]

Update on the Evaluation and Management of Portal Hypertension

Abstract: The development of clinically significant portal hypertension (CSPH) in patients with chronic liver disease is an important predictor of varices, variceal hemorrhage, ascites, hepatic encephalopathy, […]

Overview of Current Management of Portal Hypertension

G&H Currently, what are the most common causes of portal hypertension? GG-T Portal hypertension is high pressure in the portal vein, which is the vein […]

Best Use of the Transjugular Intrahepatic Portosystemic Shunt Procedure for the Management of Portal Hypertension

G&H What are the traditional treatments for portal hypertension, and how effective are they? LVW Cirrhosis is a major cause of portal hypertension, which has consequences […]

The Use of Nonselective Beta Blockers for Treatment of Portal Hypertension

G&H What are the various stages of portal hypertension? GG-T Portal hypertension, which simply refers to an increase in portal pressure, can occur in different […]

The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis

Abstract: Thrombocytopenia is a well-known complication of liver cirrhosis. Although the pathogenesis of thrombocytopenia is not well understood, splenic congestion resulting from portal hypertension is […]